|    Join     |    Donate    |   Store    |   About NAMS

Blog: MenoPause ~ take time to think about it

In younger women, HT does not harm cognitive function

by Margery Gass | Jul 03, 2013
The WHIMSY trial released somewhat reassuring data last week:  for women ages 50 to 55, using hormone therapy (HT) will neither harm nor benefit their cognitive function.  WHIMSY examined 1,272 Women’s Health Initiative (WHI) participants who were ages 50 to 55 when they began taking HT or placebo and reported on their cognitive health about 7.2 years after they stopped the medication.

In some ways, this data was disappointing, as it did not support the “window of opportunity” theory that taking HT close to menopause maintains and benefits health. However, this theory does have evidence of benefit regarding women’s risk of cardiovascular disease, coronary heart disease, heart attack, and atherosclerosis.

Here at NAMS, we counsel that the decision of whether to take HT must be individualized for each woman, considering her overall health, severity of symptoms, quality-of-life priorities, and personal risk factors. We know that the risks of HT use in healthy women ages 50 to 59 are low. In older women, however, HT is associated with greater risks: A related WHI trial (WHIMS) found that HT use in women ages 65 to 79 caused a near doubling of rates of dementia, higher rates of cognitive decline over time, and decreased brain volume.

The bottom line of the new WHIMSY results is that younger women can be reassured that, if they choose to take HT for their symptoms, it will not harm their cognitive function or cause dementia.



Before posting a comment please review the following policies.

Comment

  1.    
     
     
      
       

MenoPause: the blog!

Posts to our Blog are written by NAMS staff members and Dr. Margery Gass. All posts are reviewed and edited by Dr. Gass. We strive to bring you the most recent and interesting information about various aspect of menopause and midlife health. We accept no advertising for our website. We want you to have accurate, unbiased, evidence-based information. 

Margery L.S. Gass, MD, NCMP
NAMS Executive Director

An internationally recognized leader in the field of menopause, Dr. Gass became Executive Director of The North American Menopause Society in 2010. Dr. Gass has been an investigator on numerous research projects, including serving as a principal investigator for the Women’s Health Initiative, and has published and presented on a wide range of topics related to menopause, including osteoporosis, sexual dysfunction, and hormone therapy.

Categories

Recent posts

Copyright© 2014 |  Home  |  Privacy Policy  |   Site Map |
This website is certified by Health On the Net Foundation. Click to verify.

This site complies
with the HONcode
standard
 
for
trustworthy health

information:
verify here.

5900 Landerbrook Drive, Suite 390 - Mayfield Heights, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
close
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 7 + 8.